Brainomix

Brainomix is a UK software company specialising in AI-powered imaging biomarkers and Software as a Medical Device (SaMD) to support clinical decision-making in stroke, lung fibrosis, and cancer.

Its platform provides clinicians with automated imaging analysis to guide treatment decisions in acute stroke care and is used in more than 30 countries.

It is a spinout from the University of Oxford, based in Oxford.